Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017

United States115e CongrèsHR-2410House of Representatives
Mis à jour : 27 févr. 2018

Résumé

Aucun résumé n’est disponible.

Textes du projet de loi

Versions disponibles
Consulter le texte officiel

3 versions disponibles

Chronologie

  1. Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote.(text: CR H1240-1241)

  2. On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H1240-1241)

    House of Representatives

  3. Motion to reconsider laid on the table Agreed to without objection.

    House of Representatives

  4. Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

    Senate